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Phenylalanine hydroxylase (PAH) is a tetrahydrobiopterin (BH4)-dependent enzyme that catalyzes the hydroxylation of L-Phe to
L-Tyr. The non-heme iron in the enzyme (Fe(III) as isolated) is 6-coordinated to a 2-His-1-carboxylate motif and three water mol-
ecules (wat1, wat2 and wat3). Tyr325 is at the second coordination sphere, hydrogen-bonded to water (wat1). We prepared and
expressed mutants with Leu, Ala, Ser and Phe at this position. Only Y325L and the conservative mutation Y325F resulted in stable
enzymes, but the mutant Y325F has been found to be post-translationally hydroxylated and to revert back to wild-type PAH [S.D.
Kinzie, M. Thevis, K. Ngo, J. Whitelegge, J.A. Loo, M.M. Abu-Omar, J. Am. Chem. Soc. 125 (2003) 4710–4711], being inadequate
to investigate the early inferred functional role of Tyr325. On the other hand, compared to wild-type PAH, Y325L shows reduced
specific activity, decreased coupling efficiency and decreased iron content. The mutant also reveals a very high affinity for L-Phe and
BH4 and does not manifest positive cooperativity for the substrate. All together, our results support that the mutation Y325L causes
the removal or increased delocalization of the iron-ligated wat1 and, in turn, a less tight binding of the metal. Tyr325 thus appears to
have an important role ensuring stoichiometric binding of iron, correct geometry of the complexes with substrate and cofactor and,
consequently, a right coupling efficiency of the PAH reaction. In addition, the residue appears to be important for the correct coop-
erative regulation by L-Phe.
 2005 Elsevier Inc. All rights reserved.
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Phenylalanine hydroxylase (PAH, EC 1.14.16.1) cat-
alyzes the hydroxylation of L-Phe to L-Tyr. This reaction
is the rate-limiting step in the catabolism of L-Phe, and
mutations in the human PAH gene result in phenylke-
tonuria, which is the most common inherited disease
of amino acid metabolism [1]. The human enzyme is tet-
rameric and contains an essential non-heme iron per0162-0134/$ - see front matter  2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.jinorgbio.2005.03.005
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E-mail address: aurora.martinez@biomed.uib.no (A. Martı´nez).subunit. The reaction requires molecular oxygen and a
pterin cofactor which in fact functions as a cosubstrate
[2].The natural cofactor of PAH is tetrahydrobiopterin
(BH4), and during hydroxylation of L-Phe, the dioxygen
is partitioned between the phenolic hydroxyl group of
tyrosine and the 4a-hydroxyl group of 4a-carbinolamine
(4-HO-BH4), which is then recycled back to BH4 via
4a-carbinolamine dehydratase and dihydropteridine
reductase (DHPR) [2]. PAH is regulated by its substrate
L-Phe, which activates the enzyme and elicits positive
cooperativity; BH4 serves as a negative effector in addi-
tion to reductively activate PAH [2,3].
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human PAH, it is seen that the iron is coordinated to
Glu330, His285, His290 and three water molecules,
wat1, wat2 and wat3 [4] (Fig. 1(a)). Tyr325 is conserved
in all mammalian PAH and is located at the second
coordination sphere of the iron, hydrogen bonded to
wat1. The apparently central structural role of Tyr325
as well as its proximity to the iron early induced the sug-
gestion that this residue had an important catalytic role
in the PAH reaction [4]. Furthermore, the structures of
the binary complexes of PAH with either BH4 [5] or the
oxidized cofactor analogue dihydrobiopterin (BH2) [6]
showed the carbonyl at C4 of the pterin hydrogen bond-
ing to wat1. This hydrogen bonding network involving
Tyr325 thus appears to have a role in stabilizing the ac-
tive site and positioning the pterin cofactor. Extensive
mutagenesis studies at Tyr325 in the catalytic domains
of either human PAH [6] or rat PAH [7], or at the cor-
responding Tyr371 in the full length rat homologous en-
zyme tyrosine hydroxylase [8], did not unambiguously
confirm the significance of this residue in catalysis orFig. 1. Close up on PAH active site structure in the absence (a) (PDB
1PAH) and in the presence of the L-Phe analogue 3-(2-thienyl)-L-
alanine and BH4 (b) (PDB 1KW0). The iron is shown with its first
coordination sphere. Tyr325 is also shown.in the binding of Phe and BH4. Notably, the conserva-
tive mutation Tyr to Phe resulted in enzymes of similar
activity and affinity for the natural substrates. This
intriguing result was explained by Kinzie et al. showing
that the Y325F mutant in human PAH was rescued by
self-hydroxylation [9]. Posttranslational self-hydroxyl-
ation reactions occur in several non-heme iron enzymes
(for review see [10]). The posttranslational oxidative re-
pair of the Y325F PAH mutant to retain wild-type
structure again indicates the functional importance of
Tyr325. Accordingly, the mutation of Tyr to Phe in
the corresponding residue (Tyr179) in Chromobacterium
violaceum PAH, which is not the subject of self hydrox-
ylation, significantly decreases the catalytic activity
while increasing the apparent affinity for L-Phe [11].
The same catalytic effects accompanied the mutation
of Y325L in rat PAH [7].
We aimed to further investigate and clarify the struc-
tural and catalytic role of Tyr325 in human PAH and
prepared several mutants at this position, in addition
to Y325F, in the full-length form of the enzyme. The ki-
netic properties of the mutants have been studied in de-
tail, and electron paramagnetic resonance (EPR)
spectroscopy has been applied to characterize iron bind-
ing and iron coordination geometry. The stable mutant
Y325L turned out to be very valuable in this respect and
allowed us to characterize the role of this residue at the
second coordination sphere on the iron binding stoichi-
ometry, the positive regulation by the substrate L-Phe
and the coupling efficiency of the reaction.2. Experimental
2.1. Site-directed mutagenesis
The mutations Y325A, Y325F, Y325L and Y325S
were introduced in the human PAH cDNA by poly-
merase chain reaction (PCR)-based site-directed muta-
genesis using the QuikChangeTM kit (Stratagene).
The primers used for mutagenesis (provided by
MWG Biotech AG, Ebersberg) are shown in Table 1.
The authenticity of the mutagenesis was verified by
DNA sequencing using the primers described previ-
ously [12].
2.2. Expression and purification of the enzymes
Transformed Escherichia coli with the pMAL vectors
were grown and the enzymes were purified by affinity
chromatography on amylose resin (New England Bio-
labs) as described [13]. After cleaving the fusion protein
with enterokinase (EKMaxe from Invitrogen) using
20 units EKMaxe/mg of fusion protein at 4 C for
4 h, the tetrameric enzyme forms were isolated by size
exclusion chromatography as described [13].
Table 1
Primers used for the PCR site-directed mutagenesis
Mutant Sense Sequence
Y325A Forward 50-AAG-CTC-GCC-ACA-ATT-GCC-TGG-TTT-ACT-GTG-30
Y325A Reverse 50-CAC-AGT-AAA-CCA-GGC-AAT-TGT-GGC-GAG-CTT-3 0
Y325F Forward 50-AAG-CTC-GCC-ACA-ATT-TTC-TGG-TTT-ACT-GTG-3 0
Y325F Reverse 50-CAC-AGT-AAA-CCA-GAA-AAT-TGT-GGC-GAG-CTT-30
Y325L Forward 50-AAG-CTC-GCC-ACA-ATT-CTC-TGG-TTT-ACT-GTG-3 0
Y325L Reverse 50-CAC-AGT-AAA-CCA-GAG-AAT-TGT-GGC-GAG-CTT-3 0
Y325S Forward 50-AAG-CTC-GCC-ACA-ATT-TCC-TGG-TTT-ACT-GTG-3 0
Y325S Reverse 50-CAC-AGT-AAA-CCA-GGA-AAT-TGT-GGC-GAG-CTT-3 0
The codon changes are shown in bold type.
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PAH activity was assayed at 25 C with a standard
reaction mixture (final volume, 50 ll) of 10 lM ferrous
ammonium sulfate, 1 mM L-Phe, 5 mM dithiothreitol,
and 75 lM BH4 (6(R)-L-erythro-5,6,7,8-tetrahydrobiop-
terin from Schircks, Laboratories, Jona, Switzerland),
0.04 lg/ll catalase, 0.05% (w/v) bovine serum albumin,
and 1 lg of the various human PAH forms in 100 mM
Na-N-2-hydroxyethylpiperazine-N 0-ethanesulphonic acid
(HEPES), pH 7.0, as described [13,14]. The kinetic
parameters were determined using variable concentra-
tions of the substrate (0–5 mM L-Phe with 75 lM
BH4) and of the cofactor (0–500 lM BH4 with 1 mM
L-Phe) and were calculated by non-linear regression
analysis of the experimental data using the program Sig-
maPlot 2000 (SPSS Inc.).2.4. PAH/Dihydropteridin reductase coupled assay
A coupled assay with DHPR was used to determine
the ratio of L-Phe conversion to L-Tyr to the oxidation
of BH4 (in lmol/lmol, i.e., coupling efficiency) [15].
The assay mixture consisted of 0.01 mg/ml PAH,
100 lM ferrous ammonium sulfate, 1 mM Phe, 100 lM
BH4, 1.24 U DHPR (Sigma), 200 lM NADH (Sigma),
0.1% (w/v) bovine serum albumin and 0.04 lg/ll catalase
in 250 mMNa-HEPES, pH 7.0. The enzymes were prein-
cubated with 1 mM L-Phe (5 min, 25 C). Oxidation of
BH4 was determined by monitoring the decrease in
absorbance at 340 nm due to NADH oxidation
(e = 6220 M1 cm1) for 1 min at 25 C and the amount
of L-Tyr formed at the end of the assay was measured by
high liquid pressure chromatography and fluorimetric
detection [13]. Background levels of oxidized pterin aris-
ing from autooxidation of reduced pterin were controlled
for when calculating the levels of BH4 oxidation.2.5. Fluorescence measurements
Measurements of intrinsic tryptophan fluorescence
were performed at 25 C in 20 mM Na-HEPES, 0.2 MNaCl at pH 7.0, with 1 lM PAH subunit. A Perkin–El-
mer LS-50 luminescence spectrometer with a constant-
temperature cell holder and 1-cm path-length quartz
cells was used. The excitation and emission slits were 3
and 5, respectively. All spectra were corrected for blank
emission.
2.6. EPR spectroscopy and redox titrations
Enzyme samples (200 lM subunit) for EPR analyses
were prepared in 20 mM Na-HEPES, 0.2 M NaCl, pH
7.0. Additions and incubations (5 min, pH 7.0, 25 C)
with 5 mM L-Phe and 5 mM L-erythro-7,8-dihydrobiop-
terin (BH2) were performed prior to freezing the samples.
EPR analysis were performed at 9.66 GHz microwave
frequency on a Bruker ESP300E equipped with an Ox-
ford Instruments helium flow cryostat ESR900 at 3.6 K
and a Bruker dual mode resonator ER4116DM operated
at the perpendicular mode (TE102). Other EPR parame-
ters are given in the figure legends. The EPR spectra were
smoothed with the polynomial filter (n = 5–15) provided
in the WINEPR software (Bruker) and were base-line
corrected.
Potentiometric titrations for subsequent EPR moni-
toring were performed in a 2-ml anaerobic cell under
purified argon at 4 C. The bulk potential of the stirred
solution was measured using a platinum wire electrode
with respect to the potential of a Red Rod microsample
electrode REF200 from Radiometer Analytical. Re-
ported potentials were all expressed relative to the nor-
mal hydrogen electrode. PAH samples (100 lM
subunit) were poised at various potentials in the pres-
ence of 100 lM each of the following mediators:
N,N,N 0,N 0-tetramethyl-p-phenylenediamine, 2,6-dichlo-
rophenolindophenol, phenazine ethosulfate, methylene
blue, resorufin, indigosulfonate, phenosafranin, safranin
O, neutral red, benzyl viologen, and methyl viologen
[16]. Potassium ferricyanide (III) and sodium dithionite
were used as oxidant and reductant, respectively. Redox
equilibrium was obtained as judged by the attainment of
a stable solution potential within a few minutes after the
addition of the titrant to the reaction mixture. The sam-
ples were transferred anaerobically to EPR tubes and
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(Em) were obtained from the experimental data points
with a least squares fit to the Nernst equation (n = 1).
The EPR monitored titrations of wt-PAH and mutant
samples were performed at a microwave frequency of
9.66 GHz and a microwave power of 1 mW, with a 10-
G (0.1 mT) modulation amplitude and a modulation fre-
quency of 100 kHz at 3.6 K. P1/2 was determined by
least square fitting (by using Origin version 6.1, Origin-
Lab Corporation) to the saturation curve described by
Eq. (1), where I is the EPR amplitude, P is the micro-
wave power and the parameter b describes the contribu-
tion of inhomogeneous broadening [17]:
I / 1=ð1þ P=P 1=2Þb=2: ð1Þ2.7. Iron quantification
Iron quantification by chelation with bathophenanth-
rolinedisulphonic acid was performed essentially as de-
scribed [18]. 15 lM subunit of wt-PAH and mutants
were incubated with 1 mM L-Phe, 60 lM BH4, 1 mM
dithiothreitol at 25 C, and, after 3 min, 50 mM bath-
ophenanthrolinedisulphonic acid (Sigma) was added to
form the Fe(II)–bathophenanthroline complex and
determine the iron content using a e535 =
22,000 M1 s1 [19]. Quantification of the EPR visible
Fe(III) was performed as described [16], applying the
method developed by Aasa and Va¨nnga˚rd [20,21] to re-
gions of EPR spectra taken at several temperatures be-
tween 3.6 and 25 K, and using transferrin and ferric
myoglobin (100–200 lM) as references for the g = 4.3
and g = 6.0 iron species, respectively.3. Results
3.1. Expression and purification
The full-length PAH mutants Y325A, Y325F, Y325L
and Y325S were obtained by site-directed mutagenesis.
All these enzyme forms expressed well in E. coli, butTable 2
Steady-state kinetic parameters for the tetrameric forms of wt-PAH and the
Enzyme Vmax
a,b (lmol Tyr/min mg)
Non L-Phe activateda L-Phe activatedb
Wt 1230 ± 300 3640 ± 360
Y325F 1150 ± 220 3630 ± 150
Y325L 1310 ± 130 1500 ± 90
Y325A 290 ± 2 300 ± 24
All measurements made at 25 C, pH 7.0. Vmax for non-L-Phe activateda and K
Phe and variable concentrations of BH4 (0–200 lM). Vmax for L-Phe activate
Hill coefficient (h) for L-Phe were determined at 75 lM BH4 and variable co
5 min (25 C, pH 7.0) with L-Phe at the same concentrations as in the assay.
activity.Y325S quickly aggregated after purification and was
not suitable for a detailed characterization. Y325A also
showed a high degree of aggregation but we were able to
obtain sufficient tetrameric form for a partial character-
ization of the steady-state kinetic properties. The mu-
tants Y325F and Y325L were stable and were
obtained at similar yields and oligomeric distribution
as wild-type (wt) PAH, consisting mainly of tetrameric
forms which were purified to homogeneity.
3.2. Steady-state kinetic analysis of the hydroxylating
reaction
In order to exhibit maximal specific activity with the
natural cofactor BH4, PAH must be preincubated with
its substrate L-Phe, which binds with positive coopera-
tivity (Hill coefficient, h  2) [3] and induces a regula-
tory activating conformational change and 3-fold
increase in the activity. The specific activities for the
enzyme forms prior to and after preincubation with
L-Phe are summarized in Table 2. As expected [9],
Y325F showed indistinguishable properties to wt-
PAH. On the other hand, the mutant Y325L appears
to be appropriate to investigate the early suspected role
of Tyr325 on the structure and function of the enzyme
[4]. The mutation to Leu does not affect the conforma-
tional stability of the enzyme (see above) but the mu-
tant shows lower hydroxylating activity and no
cooperativity for L-Phe (h = 1.1) (Fig. 2 and Table 2).
Remarkably, this mutant displays a significantly lower
S0.5(Phe)-value (concentration of L-Phe giving
half-maximal activity), approaching the value for the
activated forms [22]. This increase in affinity is accom-
panied by a concomitant increase in substrate inhibi-
tion, which is manifested at [L-Phe] > 500 lM, vs
1 mM for wt-PAH (Fig. 2). The Km(BH4) was also re-
duced in Y325L, indicating a higher affinity for both
the substrate and cofactor (Table 2). The mutation of
the tyrosine to alanine significantly reduced the activity
of the enzyme and, as Y325L, Y325A did not show
any further activation by preincubation with L-Phe
(Table 2).mutants at position Tyr325
S0.5(L-Phe) (lM) Km(BH4) (lM) h(L-Phe)
154 ± 20 28 ± 7 2.0
184 ± 83 27 ± 2 1.9
57 ± 28 8 ± 1 1.1
–c –c –c
m(BH4) were calculated without preincubation with L-Phe, at 1 mM L-
d,b the concentration of L-Phe at half maximal activity (S0.5), and the
ncentrations of L-Phe (0–5 mM). The enzymes were preincubated for
cThese parameters could not be determined for this mutant due to low
Fig. 2. Effect of L-Phe concentration on the catalytic activity of wt-
PAH (d) and Y325L (s). The activity was measured at standard assay
conditions (75 lM BH4, 1 min assay, 25 C) with 5 min preincubation
of the enzymes at the corresponding concentrations of L-Phe at 25 C.
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While oxidation of the cofactor BH4 is tightly cou-
pled to formation of L-Tyr during normal enzyme
turnover with L-Phe as substrate, the use of alternative
substrates or cofactor analogues often results in
uncoupling during PAH turnover, with a higher ratio
of cofactor oxidation, i.e., electrons used, per sub-
strate hydroxylation [15,23]. A partially uncoupled
reaction has also been described for the two phenylke-
tonuria associated mutations R158Q and E280K [24].
These partially uncoupled reactions are concomitantly
associated to reduced specific activity measured as
amino acid hydroxylation and to H2O2 production
from the electrons not used for product formation
[15,24]. Spectroscopic evidence revealed that the muta-
tions R158Q and E280K also caused alterations in the
iron coordination, thus rendering the protein less ac-
tive [24]. As seen in Table 3, the mutants Y325L
and Y325A, but not Y325F, also present uncoupling
of the reaction (30% (Y325L) and 80% (Y325A) of
non-productive turnovers with respect to L-Tyr
formation).Table 3
Coupling efficiency of wt-PAH and the mutants at position Tyr325
Enzyme Tyr produced
(lmol Tyr/
min mg)
BH4 consumed
(lmol NADH/
min mg)
Coupling
(lmol L-Tyr/
lmol BH4)
Wt 3480 ± 160 3550 ± 180 0.98
Y325F 3250 ± 400 3010 ± 350 1.08
Y325L 770 ± 50 1120 ± 230 0.69
Y325A 75 ± 5 390 ± 5 0.19
Measured at pH 7.0 at 25 C in the presence of DHPR and NADH.3.4. Fluorescence emission spectra
In order to investigate if the reason why the mutant
Y325L did not show positive cooperativity and activa-
tion by L-Phe was an impediment to undergo the activat-
ing L-Phe induced conformational change, we studied
the conformation of the enzyme in the absence and pres-
ence of L-Phe by fluorescence spectroscopy. Human
PAH contains three conserved tryptophan residues
(120, 187 and 326). Activation of PAH by L-Phe has
been shown to result in an increase of the intrinsic tryp-
tophan fluoresce and a red shift of the emission maxi-
mum [25,26]. These changes are largely contributed by
Trp120, which is supposed to exchange to a more polar
environment, most probably the solvent, upon activa-
tion of the enzyme [27]. In the absence of added L-Phe,
the tryptophan fluorescence emission spectrum of
Y325L shows a maximum at about 337 nm (excitation
at 295 nm) and, on incubation with 1 mM L-Phe, a 10
nm red-shift and an increase in the quantum yield is ob-
served (Fig. 3). This is very similar to that observed with
wt-PAH [22,27] and the silent mutant Y325F (data not
shown). Thus, the activating conformational change in-
duced by L-Phe seems to be operational in the mutant,
and the lack of cooperativity observed in the activity
measurements rather seems to be related to the low
S0.5(Phe)-value which corresponds to that of a preacti-
vated PAH.
3.5. EPR spectroscopy
The ferric ion with 5 unpaired d-electrons is a high
spin 5/2 system. Systems with S > 1/2 can be described
by the standard spin Hamiltonian:
HS ¼ b  S  g  Bþ D½S2z  SðS þ 1Þ=3þ E=DðS2x  S2yÞFig. 3. Fluorescence emission spectra of the Y325L mutant of PAH.
The enzyme sample was diluted to a final concentration of about 1 lM
subunit in 20 mM Na-HEPES, 0.2 M NaCl, pH 7.0. Fluorescence
spectra were acquired in the absence (—) and presence (- - -) of 1 mM
L-Phe. The excitation wavelength was 295 nm.
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field, g the Lande´ tensor and D and E zero-field splitting
parameters are the axial and the rhombic parameters,
respectively. The g, D, and E parameters in the standard
spin Hamiltonian are important when discussing EPR
spectra, and may give information about the metal-li-
gand environments [28]. The broad nature of the Fe(III)
EPR spectra makes the determination of D and E
difficult but computer simulation of the spectra provides
E/D, which although cannot be used to predict geometry
(i.e., tetrahedral versus octahedral), is a structurally use-
ful parameter that indicates the distortion of the coordi-
nation geometry. Thus, |E/D| ranges between 0 and 1/3
where |E/D| = 0 corresponds to the fully axial case and
|E/D| = 1/3 the fully rhombic case. As earlier described
for both the rat [29–31] and human enzymes [16], the
X-band EPR spectrum of PAH shows a major signal
at geff  4.3 (160 mT), characteristic of rhombic
(|E/D| = 0.33) high-spin (5/2) Fe (III) (Fig. 4(a)) from
the middle Kramers doublet. These types of water-coor-
dinated Fe(III) EPR signals are rather broad and non-
resolved, and any sharp signals from the lower Kramers
doublet in X-band EPR just below geff  9.7 are hardly
seen, indicating both g- and D-strain. The spectra do not
contain additional signals that could be associated to,
e.g., radicals, but PAH samples usually include some
contamination with small amounts of Cu(II) giving sig-
nals at the high-field region around g = 2, and this re-
gion of the spectrum is not usually shown. Similar
EPR properties were observed for the mutants Y325L
and Y325F, but Y325L had even less defined high spin
Fe(III) EPR spectrum. At similar protein concentration
Y325F presents a signal at geff  4.3 which was similarFig. 4. EPR spectra of wt-PAH (a) and Y325L (b) as isolated. The
samples (200 lM enzyme subunit) were prepared in 20 mM Na-
HEPES, 0.2 M NaCl, pH 7.0. EPR parameters were 9.66 GHz
microwave frequency, 1 mW microwave power, 1 mT modulation
amplitude, and a modulation frequency of 100 kHz at 3.6 K.to that of wt-PAH, but Y325L shows a weaker signal,
and the spectrum of this mutant also reveals an addi-
tional minor signal from a lower Kramers doublet spe-
cies at 115 mT g^ = 6 and gi = 2 (Fig. 4(b)), indicating
the presence of an additional small iron population with
axial symmetry of the zero-field splitting (|E/D| = 0) [28].
Integration of the EPR signal at g = 4.3 and quantifica-
tion of the iron content for the wt-PAH and the mutant
forms proved that the content of iron per enzyme was
nearly stoichiometric for wild-type and the Y325F mu-
tant, while Y325L only had 0.5 atom/subunit (Table
4). Similar substoichiometric iron content for this mu-
tant was determined by using bathophenanthrolinedisul-
phonic acid (Table 4). EPR spectra and iron
quantifications of the wild-type and mutants taken prior
and after addition of equimolar amounts of potassium
ferri(III)cyanide were similar, indicating that the en-
zymes were isolated with the iron mainly in the ferric
state. Also, while it is possible to reconstitute the iron-
saturated full active wt-PAH from the iron-free apoen-
zyme by incubation with ferrous iron [18], the same
cannot be obtained for the substoichiometrically iron-
saturated mutant Y325.
Upon addition of substrate L-Phe and cofactor ana-
logue BH2 to the enzyme samples we observed the previ-
ously reported changes induced in the EPR spectra of
wt-PAH [16] also in the spectra of the mutants Y325F
and Y325L, but the changes were less clear in the mutant
Y325L due to the already broad signals before any li-
gand addition (data not shown). The simultaneous addi-
tion of both ligands leads to the disappearance of the
geff = 6.0 signal in the spectra of this mutant (data not
shown). Moreover, we determined the midpoint poten-
tial (Em(Fe(III)/Fe(II))) for the active site iron in
Y325L by monitoring and measuring the intensity of
the major signal at geff = 4.3 during the redox titrations.
The Fe(III) ion was reduced in the range of +50 to +400
mV and the Em-value was calculated to be 200 ± 13 mV
(data not shown), not very different from that previously
determined for wt-PAH in the absence of ligands, i.e.,
+207 ± 10 mV [16]. The low intensity of the signal at
geff = 6.0 hindered redox titration and the calculation
of the Em for the minor iron species.
While the signal at g = 6.0 in the EPR spectra of the
mutant Y325L seems to correspond to a minor andTable 4
Iron content for wt-PAH and mutants Y325L and Y325F, determined
using the chelation with bathophenanthrolinedisulphonic acid and by
EPR
Enzyme Fe/subunit (lM/lM) EPR
Bathophenanthroline
Wt 1.04 1.0
Y325L 0.65 0.5
Y325F 1.03 0.8
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at g = 4.3, it is not clear if this latter signal represents an
iron form identical to that with the same g-value in the
spectrum of wt-PAH. Indeed, the different bandwidth
and shape of these signals (g = 4.3 region in Fig. 4(a)
and (b)) indicate different iron species in the wt-PAH
and the mutant. Nevertheless, the analysis of the micro-
wave power saturation for the unligated and ligated
samples did not manifest large differences between the
irons in both enzyme forms (Fig. 5). Thus, at 3.6 K,Fig. 5. Microwave power saturation analyses. Saturation behavior at
two different temperatures, 3.6 K (a) and 10 K (b), of the paramagnetic
species observed at geff = 4.3 in EPR spectra of wild-type PAH in the
absence (n) or presence of 5 mML-Phe and 5 mMBH2 (s), or ofmutant
Y325L in the absence (n) or presenceof 5 mML-Pheand5 mMBH2 (,).
(c) Power saturation behavior of the EPR species at geff = 6.0 in samples
of the mutant Y325L, at 3.6 K (n) or 10 K (s). The curves were fitted
using Eq. (1) with an inhomogeneity factor: b  1.the half-saturation microwave power (P1/2) of the iron
signal at g = 4.3 of the wt-PAH was 1.1 ± 0.1 mW for
the unbound enzyme and increased to 3.6 ± 0.4 mW in
the presence of L-Phe and BH2, while the unligated
and ligated mutant showed P1/2 between these values
(Fig. 5(a)). Moreover, at 10 K, the P1/2 of the g = 4.3
component was 8.9 ± 1.4 mW for the unbound forms
of both wt-PAH and Y325L and increased to
14.8 ± 1.9 for the ligand bound enzyme forms (Fig.
5(b)). The signals from both enzyme samples showed
normal microwave power behavior with b value close
to 1 at both 3.6 K and 10 K (Figs. 5(a) and (b)). While
these analyses indicate that the coordination environ-
ment of the major iron species is only slightly altered
in the mutant with respect to the wt-PAH, the geff = 6.0
component of the spectra of Y325L did not show nor-
mal microwave power saturation behavior, and it seems
not even partially saturated at 200 mW (Fig. 5(c)), fur-
ther demonstrating that this minor component corre-
sponds to a different iron species. The saturation
behavior of this small amount Fe(III) is not common,
but the low intensity of the g = 6.0 signal precludes
the correct molecular interpretation of its saturation
data.4. Discussion
Despite the early suspected role of Tyr325 in the
function of PAH [32], the conservative mutation to
Phe is not appropriate to investigate the functional
and structural importance of this residue due to the
reversal of the mutant back to wt-PAH by posttransla-
tional hydroxylation [9]. Accordingly, the mutant
Y325F prepared in this work in full-length PAH showed
indistinguishable properties to wt-PAH. On the other
hand, the mutant Y325L is advantageous to study this
location in the enzyme: opposite to mutations to Ala
and Ser (Y325A and Y325S), the mutation to Leu does
not have a deleterious effect on the conformational sta-
bility of the protein but has significant effects on the cat-
alytic properties. Thus, despite its high affinity for both
substrate and cofactor (Table 1) the Y325L mutant
shows a reduced activity at standard conditions (1 mM
L-Phe, 75 lM BH4) due to high substrate inhibition
(Fig. 2) and low coupling efficiency resulting in unpro-
ductive oxidation of BH4. The lower Fe content also
contributes to the reduced activity. Interestingly, despite
the defective catalysis and regulation of the Y325L mu-
tant, its catalytic efficiency measured as Vmax/S0.5(Phe)
is comparable to that of wt-PAH. The most deleterious
consequences of mutating Tyr325 are in fact the loss of
iron and the uncoupling of the reaction. Loss of iron has
been shown to result in a decreased conformational sta-
bility of the protein both for bacterial (C. violaceum)
PAH [11] and for tyrosine hydroxylase [33]. The effects
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structural role of this residue by determining the close
structure of the active site around the metal (Fig.
1(a)). Mutation of the homologous residue in the bacte-
rial enzyme (Tyr179) did reveal its important role in
catalysis but for that enzyme it was concluded that iron
binding to the active site was not dependent on the pres-
ence of a Tyr at this position [11].
In full-length human PAH, the substoichiometric me-
tal binding and the altered iron coordination geometry
as observed by EPR are in agreement with a mutation-
induced loss of the hydrogen bond between the side
chain and wat1 at the first coordination sphere of the
catalytic iron. The signal at geff = 6.0 observed in the
EPR spectrum of the Y325L mutant is indicative of a
minor iron species with axial symmetry of the zero-field
splitting (|E/D| = 0) [28], while the geff = 4.3 signal indi-
cates a rhombic symmetry of the zero-field splitting
(|E/D| = 0.33). The axial coordination geometry is often
observed for heme Fe(III) and is less common for non-
heme Fe(III) proteins, but it has been observed for, e.g.,
lipoxygenase [34] and in catechol complexes of PAH and
tyrosine hydroxylase [35,36]. In PAH the enzymatic ac-
tive iron can be converted to axial species under different
conditions [16,29,30].
The rhombic geometry observed for the iron in the
resting unligated ferric state of wt-PAH by EPR is in
accordance with the six-coordinate distorted octahedral
site revealed by both crystallography (Fig. 1(a)) and X-
ray absorption spectroscopy for the ferrous form [4,37].
The ferrous active site adopts a five-coordinate square
pyramidal structure upon substrate analogue and cofac-
tor binding, which results in the bidentate coordination
of the glutamate ligand and the elimination of two water
ligands [37,38]. Release of a soft ligand, usually water,
upon substrate binding is a common feature in several
non-heme iron proteins containing the 2-His-1-carbox-
ylate facial triad motif [39,40]. Releasing of the water li-
gand occurs trans to any of the three residues in the
coordinating motif, allowing the binding of O2 [39].
Wat1, which is hydrogen bonded (2.8 A˚) to Tyr325, is
trans to His 285 and is released upon cofactor and sub-
strate binding (Fig. 1(b)). The substitution of this resi-
due by a leucine would disrupt the hydrogen-bonding
network between the iron, wat1, and the phenolate oxy-
gen in Tyr325 and would result in both the delocaliza-
tion and/or partial release of this water ligand and the
reorganization of the first coordination sphere of the fer-
ric iron, in accordance with (i) the increased axial geom-
etry of part of the iron environment, (ii) the lower
affinity for the iron in the mutant, and (iii) the higher
P1/2 values of the signal at g = 6.0, and to less degree
at g = 4.3, indicative of a higher heterogeneity of the
iron coordination environment. Moreover, the low
S0.5(Phe) and Km(BH4) values in Y325L (Table 1) are
also in agreement with the binding of the ligands beingfacilitated when wat1 binds less tighter or is absent,
since this water would behave as a competitive ligand
to substrate and cofactor binding in wt-PAH. Mutation
of Tyr325 in the rat enzyme [7], or of the corresponding
residue in C. violaceum [11] and tyrosine hydroxylase
(Tyr371) [8], also are accompanied by a higher affinity
for L-Phe. This higher binding affinity for the substrates
does not seem to be paralleled by their correct binding in
Y325L, as indicated by the partial uncoupling of the
reaction compatible with a defective formation of the
quaternary PAH Æ Fe(II) Æ BH4 Æ Phe Æ O2 complex. In
addition, Tyr325 appears to be important for the correct
cooperative regulation of PAH by L-Phe, which is cru-
cial to maintain L-Phe homeostasis in vivo [1].
In summary, although the significant residual activity
of the mutant Y325L does not support the early hypoth-
esis that Tyr325 has an essential mechanistic role, by,
e.g., stabilizing a radical intermediate [4], our results
clearly prove the important role of this residue in human
PAH in determining the iron binding stoichiometry, the
architecture of the iron site and the right positioning of
the substrate and cofactor.5. Abbreviations
BH2 L-erythro-7,8-dihydrobiopterin
BH4 (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin
DHPR dihydropteridin reductase
Em midpoint oxidation–reduction potential
EPR electron paramagnetic resonance
HEPES N-2-hydroxyethylpiperazine-N 0-
ethanesulphonic acid
PAH phenylalanine hydroxylase
PCR polymerase chain reaction
P1/2 microwave power at 50% saturation of the
EPR signal
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